Literature DB >> 21906862

The risk of infection-related hospitalization with decreased kidney function.

Lorien S Dalrymple1, Ronit Katz, Bryan Kestenbaum, Ian H de Boer, Linda Fried, Mark J Sarnak, Michael G Shlipak.   

Abstract

BACKGROUND: Moderate kidney disease may predispose to infection. We sought to determine whether decreased kidney function, estimated by serum cystatin C level, was associated with the risk of infection-related hospitalization in older individuals. STUDY
DESIGN: Cohort study. SETTING &amp; PARTICIPANTS: 5,142 Cardiovascular Health Study (CHS) participants with measured serum creatinine and cystatin C and without estimated glomerular filtration rate (eGFR) <15 mL/min/1.73 m(2) at enrollment. PREDICTOR: The primary exposure of interest was eGFR using serum cystatin C level (eGFR(SCysC)). OUTCOME: Infection-related hospitalizations during a median follow-up of 11.5 years.
RESULTS: In adjusted analyses, eGFR(SCysC) categories of 60-89, 45-59, and 15-44 mL/min/1.73 m(2) were associated with 16%, 37%, and 64% greater risk of all-cause infection-related hospitalization, respectively, compared with eGFR(SCysC) ≥90 mL/min/1.73 m(2). When cause-specific infection was examined, eGFR(SCysC) of 15-44 mL/min/1.73 m(2) was associated with an 80% greater risk of pulmonary and 160% greater risk of genitourinary infection compared with eGFR(SCysC) ≥90 mL/min/1.73 m(2). LIMITATIONS: No measures of urinary protein, study limited to principal discharge diagnosis.
CONCLUSIONS: Lower kidney function, estimated using cystatin C level, was associated with a linear and graded risk of infection-related hospitalization. These findings highlight that even moderate degrees of decreased kidney function are associated with clinically significant higher risks of serious infection in older individuals. Copyright Â
© 2012 National Kidney Foundation, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21906862      PMCID: PMC3288732          DOI: 10.1053/j.ajkd.2011.07.012

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  23 in total

1.  Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.

Authors:  Michael Allon; Thomas A Depner; Milena Radeva; James Bailey; Srinivasan Beddhu; David Butterly; Daniel W Coyne; Jennifer J Gassman; Allen M Kaufman; George A Kaysen; Julia A Lewis; Steve J Schwab
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

2.  In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease.

Authors:  Nancy S Jenny; Russell P Tracy; Malcolm S Ogg; Le Ahn Luong; Lewis H Kuller; Alice M Arnold; A Richey Sharrett; Steve E Humphries
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

3.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

4.  Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.

Authors:  E Coll; A Botey; L Alvarez; E Poch; L Quintó; A Saurina; M Vera; C Piera; A Darnell
Journal:  Am J Kidney Dis       Date:  2000-07       Impact factor: 8.860

Review 5.  Molecular aspects of T- and B-cell function in uremia.

Authors:  M Girndt; M Sester; U Sester; H Kaul; H Köhler
Journal:  Kidney Int Suppl       Date:  2001-02       Impact factor: 10.545

6.  Infection-related hospitalizations in older patients with ESRD.

Authors:  Lorien S Dalrymple; Kirsten L Johansen; Glenn M Chertow; Su-Chun Cheng; Barbara Grimes; Ellen B Gold; George A Kaysen
Journal:  Am J Kidney Dis       Date:  2010-07-08       Impact factor: 8.860

Review 7.  Immunologic defects and vaccination in patients with chronic renal failure.

Authors:  E L Pesanti
Journal:  Infect Dis Clin North Am       Date:  2001-09       Impact factor: 5.982

8.  Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults.

Authors:  E Vinge; B Lindergård; P Nilsson-Ehle; A Grubb
Journal:  Scand J Clin Lab Invest       Date:  1999-12       Impact factor: 1.713

9.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 10.  Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review.

Authors:  R Vanholder; S Ringoir
Journal:  J Am Soc Nephrol       Date:  1993-03       Impact factor: 10.121

View more
  51 in total

1.  Hospital-acquired Clostridium difficile infection: determinants for severe disease.

Authors:  J M Wenisch; D Schmid; H-W Kuo; E Simons; F Allerberger; V Michl; P Tesik; G Tucek; C Wenisch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

2.  Kidney function and prevalent and incident frailty.

Authors:  Lorien S Dalrymple; Ronit Katz; Dena E Rifkin; David Siscovick; Anne B Newman; Linda F Fried; Mark J Sarnak; Michelle C Odden; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

3.  Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.

Authors:  Yanbei Sun; Lijuan Jiang; Xiaonan Shao
Journal:  Int Urol Nephrol       Date:  2017-09-27       Impact factor: 2.370

4.  CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Junichi Ishigami; Morgan E Grams; Alexander R Chang; Juan J Carrero; Josef Coresh; Kunihiro Matsushita
Journal:  Am J Kidney Dis       Date:  2016-11-22       Impact factor: 8.860

5.  eGFR and the Risk of Community-Acquired Infections.

Authors:  Hong Xu; Alessandro Gasparini; Junichi Ishigami; Khaled Mzayen; Guobin Su; Peter Barany; Johan Ärnlöv; Bengt Lindholm; Carl Gustaf Elinder; Kunihiro Matsushita; Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-17       Impact factor: 8.237

6.  Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Junichi Ishigami; Jonathan T Taliercio; Harold I Feldman; Anand Srivastava; Raymond R Townsend; Debbie L Cohen; Edward J Horwitz; Panduranga Rao; Jeanne Charleston; Jeffrey C Fink; Ana C Ricardo; James Sondheimer; Teresa K Chen; Myles Wolf; Tamara Isakova; Lawrence J Appel; Kunihiro Matsushita
Journal:  J Am Soc Nephrol       Date:  2020-06-23       Impact factor: 10.121

Review 7.  When kidneys and lungs suffer together.

Authors:  Claudio Sorino; Nicola Scichilone; Claudio Pedone; Stefano Negri; Dina Visca; Antonio Spanevello
Journal:  J Nephrol       Date:  2018-12-06       Impact factor: 3.902

Review 8.  Update on cystatin C: incorporation into clinical practice.

Authors:  Michael G Shlipak; Monica D Mattes; Carmen A Peralta
Journal:  Am J Kidney Dis       Date:  2013-05-20       Impact factor: 8.860

9.  Creatinine clearance rate predicts prognosis of patients with systemic lupus erythematosus: a large retrospective cohort study.

Authors:  Jiahuan Ge; Ziyi Jin; Xuebing Feng; Wenyou Pan; Lin Liu; Min Wu; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2020-11-05       Impact factor: 2.980

10.  Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: the Framingham Offspring Study.

Authors:  Christine K Liu; Asya Lyass; Joseph M Massaro; Ralph B D'Agostino; Caroline S Fox; Joanne M Murabito
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-02       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.